Works matching IS 17574676 AND DT 2010 AND VI 2 AND IP 9

Results: 6

Transparency and accountability.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 329, doi. 10.1002/emmm.201000094
By:
- Pulverer, Bernd
Publication type:
Article
Pathogens under scrutiny in the south of France.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 331, doi. 10.1002/emmm.201000087
By:
- Caldeira, Sandra;
- Dumenil, Guillaume
Publication type:
Article
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 371, doi. 10.1002/emmm.201000093
By:
- Smith, Kristen M.;
- Datti, Alessandro;
- Fujitani, Mayumi;
- Grinshtein, Natalie;
- Zhang, Libo;
- Morozova, Olena;
- Blakely, Kim M.;
- Rotenberg, Susan A.;
- Hansford, Loen M.;
- Miller, Freda D.;
- Yeger, Herman;
- Irwin, Meredith S.;
- Moffat, Jason;
- Marra, Marco A.;
- Baruchel, Sylvain;
- Wrana, Jeffrey L.;
- Kaplan, David R.
Publication type:
Article
Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 335, doi. 10.1002/emmm.201000092
By:
- Kazemi-Esfarjani, Parsa;
- La Spada, Albert R.
Publication type:
Article
Cycling through metabolism.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 338, doi. 10.1002/emmm.201000089
By:
- Aguilar, Victor;
- Fajas, Lluis
Publication type:
Article
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.
Published in:
EMBO Molecular Medicine, 2010, v. 2, n. 9, p. 349, doi. 10.1002/emmm.201000084
By:
- McConoughey, Stephen J.;
- Basso, Manuela;
- Niatsetskaya, Zoya V.;
- Sleiman, Sama F.;
- Smirnova, Natalia A.;
- Langley, Brett C.;
- Mahishi, Lata;
- Cooper, Arthur J. L.;
- Antonyak, Marc A.;
- Cerione, Rick A.;
- Li, Bo;
- Starkov, Anatoly;
- Chaturvedi, Rajnish Kumar;
- Beal, M. Flint;
- Coppola, Giovanni;
- Geschwind, Daniel H.;
- Ryu, Hoon;
- Xia, Li;
- Iismaa, Siiri E.;
- Pallos, Judit
Publication type:
Article

Works matching IS 17574676 AND DT 2010 AND VI 2 AND IP 9

Transparency and accountability.

Pathogens under scrutiny in the south of France.

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease.

Cycling through metabolism.

Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.